ERBB2 and breast cancer: Among the PAM50 breast cancer subtypes, patients with HER2-enriched breast cancer had the highest ARL scores (P < 0.001), whereas those with luminal A breast cancer had the lowest scores (Figure 3F) (P < 0.05).